Complete ICD-10-CM coding and documentation guide for Chronic Myelogenous Leukemia. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Complete code families applicable to Chronic Myelogenous Leukemia
Chronic myelogenous leukemia, BCR/ABL-positive
This range covers all phases of CML, including chronic, accelerated, and blast crisis, with specific codes for remission status.
Atypical chronic myeloid leukemia, BCR/ABL-negative
This range is used for CML cases that are BCR/ABL-negative, requiring different diagnostic criteria.
Compare key differences between these codes to ensure accurate selection
Code | Description | When to Use | Key Documentation |
---|---|---|---|
C92.10 | Chronic myelogenous leukemia, BCR/ABL-positive, not having achieved remission | Use when CML is active and not in remission. |
|
C92.11 | Chronic myelogenous leukemia, BCR/ABL-positive, in remission | Use when CML is in remission, confirmed by molecular testing. |
|
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Essential facts and insights about Chronic Myelogenous Leukemia
Use when CML is in remission, confirmed by molecular testing.
Document molecular remission status clearly.
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Personal history of leukemia
Z85.21Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Avoid these common documentation and coding issues when documenting Chronic Myelogenous Leukemia to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C92.10.
Clinical: Inaccurate treatment monitoring, Regulatory: Non-compliance with coding standards, Financial: Potential for claim denials
Regularly update patient records with remission status, Train staff on documentation requirements
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with ICD-10 specificity requirements., Data Quality: Poor data quality affecting clinical outcomes tracking.
Use C92.1x codes with specific documentation of BCR/ABL status and remission.
Inadequate documentation of remission status can lead to audit issues.
Implement regular audits of patient records for remission documentation.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Common questions about ICD-10 coding for Chronic Myelogenous Leukemia, with expert answers to help guide accurate code selection and documentation.
Use these documentation templates to ensure complete and accurate documentation for Chronic Myelogenous Leukemia. These templates include all required elements for proper coding and billing.
Need help with ICD-10 coding for Chronic Myelogenous Leukemia? Ask your questions below.